Insider · CIK 0001352620

Hasnain Faheem

Reports to the SEC for 11 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001352620

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-24	GOSSGossamer Bio, Inc. · Pre-Funded Warrant (Right to Buy)A Award	Director, President & CEO	AAward	+166 sh	$1000.00	+$166K	166
2026-08-24	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+5.8M sh	—	—	5,800,051
2026-06-04	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+35K sh	—	—	35,000
2026-03-19	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−545K sh	—	—	0
2026-03-19	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+1.54M sh	—	—	1,540,000
2026-03-19	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+1.31M sh	—	—	1,312,500
2026-03-19	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+545K sh	—	—	544,500
2026-03-19	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+650K sh	—	—	650,000
2026-03-19	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−1.54M sh	—	—	0
2026-03-19	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−438K sh	—	—	0
2026-03-19	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−545K sh	—	—	0
2026-03-19	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+545K sh	—	—	544,500
2026-03-19	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+43.5K sh	—	—	43,500
2026-03-19	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+47K sh	—	—	47,000
2026-03-19	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−47K sh	—	—	0
2026-03-19	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−1.68M sh	—	—	0
2026-03-19	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−650K sh	—	—	0
2026-03-19	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+1.68M sh	—	—	1,680,000
2026-03-19	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+325K sh	—	—	325,000
2026-03-19	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−325K sh	—	—	0
2026-03-19	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−43.5K sh	—	—	0
2026-03-19	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−1.31M sh	—	—	0
2026-03-19	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+438K sh	—	—	437,500
2026-01-02	GOSSGossamer Bio, Inc.A Award	Director, President & CEO	AAward	+280K sh	—	—	837,793
2026-01-02	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+1.68M sh	—	—	1,680,000
2025-12-09	KURAKura Oncology, Inc.S Sale	Director	SSale	−10K sh	$10.98	−$110K	23,983
2025-12-09	KURAKura Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$3.12	+$31.2K	33,983
2025-10-01	GOSSGossamer Bio, Inc.A Award	Director, President & CEO	AAward	+438K sh	—	—	557,793
2025-06-05	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+28.5K sh	—	—	28,500
2025-03-21	KURAKura Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+22.7K sh	$6.32	+$143K	46,665
2025-03-21	KURAKura Oncology, Inc.S Sale	Director	SSale	−22.7K sh	$8.00	−$181K	23,983
2025-03-04	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+1.54M sh	—	—	1,540,000
2024-06-21	GOSSGossamer Bio, Inc.P Purchase	Director, President & CEO	PPurchase	+372K sh	$0.67	+$250K	5,408,073
2024-06-05	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+26K sh	—	—	26,000
2024-03-27	GOSSGossamer Bio, Inc.S Sale	Director, President & CEO	SSale	−23.2K sh	$1.16	−$26.8K	120,293
2024-01-23	Mirati Therapeutics, Inc.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−35K sh	—	—	0
2024-01-23	Mirati Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−9,702 sh	—	—	0
2024-01-23	Mirati Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−6,333 sh	—	—	9,702
2024-01-23	Mirati Therapeutics, Inc.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2024-01-23	Mirati Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−8,717 sh	—	—	16,035
2024-01-23	Mirati Therapeutics, Inc.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−10.7K sh	—	—	0
2024-01-02	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+1.31M sh	—	—	1,312,500
2023-12-29	Mirati Therapeutics, Inc.A Award	Director	AAward	+9,702 sh	$58.75	+$570K	24,752
2023-11-20	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+438K sh	—	—	437,500
2023-08-11	Mirati Therapeutics, Inc.P Purchase	Director	PPurchase	+10.8K sh	$27.80	+$300K	10,791
2023-07-24	GOSSGossamer Bio, Inc. · Common Stock Purchase WarrantsA Award	Director, President & CEO	AAward	+135K sh	$0.13	+$16.9K	135,044
2023-07-24	GOSSGossamer Bio, Inc.A Award	Director, President & CEO	AAward	+540K sh	$1.82	+$983K	5,036,073
2023-05-31	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+26K sh	—	—	26,000
2023-05-05	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+750K sh	—	—	750,000
2023-03-22	GOSSGossamer Bio, Inc.P Purchase	Director, President & CEO	PPurchase	+441K sh	$1.14	+$504K	4,495,897

Recent filings

Accepted (ET)
Aug 264
Hasnain Faheem0001352620-26-000006
SEC(opens sec.gov)
Jun 44
Hasnain Faheem0001193125-26-257901
SEC(opens sec.gov)
Mar 204
Hasnain Faheem0001352620-26-000004
SEC(opens sec.gov)

Companies

Address

3115 MERRYFIELD ROW, SUITE 120

SAN DIEGO, CA, 92121